The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America

pp_authorblistbyline
By Ann Mullally, MD
ISBN
9780323532358
発行日
11-07-2017
Hardback
$108.99 $98.09
+ WishList
This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!
その他の情報
ISBN 9780323532358
Author Informaiton By Ann Mullally, MD, Dana-Farber/Brigham and Women's Cancer Center
Pp Authortext Mullally
E-ISBN 9780323532365
Imprint Elsevier
発行日 11-07-2017
あなたのレビューを投稿する
登録ユーザーのみがレビューを書くことができます。 ログインするか、アカウントを作成してください

Back to top